Healthcare AI Governance Market to Hit $19.65B by 2035, Grand View Research

The global healthcare AI governance and safety market is projected to reach $19.65 billion by 2035, driven by escalating regulatory requirements and the need for robust risk management as AI adoption accelerates in healthcare systems Grand View Research.

The healthcare AI governance and safety market is forecasted to grow from its current size to $19.65 billion by 2035, according to a new report released in June 2024 by Grand View Research. This growth is fueled by increasing integration of AI into clinical workflows, diagnostics, and patient management, which in turn is prompting healthcare providers, payers, and technology vendors to invest heavily in governance, compliance, and safety solutions Grand View Research. The trend affects hospitals, health systems, insurers, and third-party AI vendors globally.

Rising investment in healthcare AI governance is a direct response to mounting regulatory scrutiny and evolving compliance frameworks, including the EU AI Act, HIPAA, and FDA guidelines for AI/ML-based medical devices Healthcare IT News. As AI models are increasingly used for clinical decision support and patient-facing applications, regulators are demanding transparent, auditable, and bias-mitigated systems. The EU AI Act, for example, classifies most healthcare AI as “high risk,” requiring rigorous risk management, human oversight, and post-market monitoring European Commission. In the U.S., the FDA is tightening oversight of adaptive AI/ML software as a medical device (SaMD), while HIPAA-covered entities must ensure AI systems safeguard protected health information (PHI) and comply with privacy and security rules FDA.

CTOs, CISOs, and Compliance Officers in healthcare organizations should expect increased pressure to implement AI governance frameworks, invest in compliance automation, and conduct regular risk assessments over the next 30-90 days. Procurement teams will need to vet AI vendors for regulatory readiness, while internal audit and risk management functions must prepare for more frequent and detailed regulatory reviews. Organizations lagging in AI governance maturity risk regulatory penalties, reputational harm, and operational disruption as enforcement tightens.

What This Means for Enterprise AI

Healthcare organizations must prioritize operationalizing AI governance aligned with the EU AI Act, which mandates risk management, transparency, and human oversight for high-risk AI systems European Commission. U.S. entities deploying AI in clinical or administrative settings must ensure compliance with FDA SaMD guidance and HIPAA privacy/security requirements, including robust audit trails and explainability for AI-driven decisions FDA. Immediate action items include: updating vendor due diligence checklists to include AI regulatory compliance, deploying AI risk management tools, and training staff on new governance protocols. Failure to act could result in regulatory fines, loss of payer contracts, or exclusion from key markets as global standards converge Healthcare IT News.